Does RAVULIZUMAB-CWVZ Cause Malaise? 353 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 353 reports of Malaise have been filed in association with RAVULIZUMAB-CWVZ. This represents 3.5% of all adverse event reports for RAVULIZUMAB-CWVZ.
353
Reports of Malaise with RAVULIZUMAB-CWVZ
3.5%
of all RAVULIZUMAB-CWVZ reports
3
Deaths
53
Hospitalizations
How Dangerous Is Malaise From RAVULIZUMAB-CWVZ?
Of the 353 reports, 3 (0.8%) resulted in death, 53 (15.0%) required hospitalization, and 1 (0.3%) were considered life-threatening.
Is Malaise Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RAVULIZUMAB-CWVZ. However, 353 reports have been filed with the FAERS database.
What Other Side Effects Does RAVULIZUMAB-CWVZ Cause?
Fatigue (1,472)
Asthenia (727)
Headache (639)
Drug ineffective (570)
Off label use (451)
Muscular weakness (422)
Dyspnoea (414)
Haemoglobin decreased (346)
Myasthenia gravis (338)
Back pain (326)
What Other Drugs Cause Malaise?
ADALIMUMAB (15,965)
ETANERCEPT (13,600)
METHOTREXATE (9,970)
TOFACITINIB (9,040)
SECUKINUMAB (8,570)
INFLIXIMAB (7,477)
RITUXIMAB (6,587)
PREGABALIN (6,320)
PREDNISONE (6,319)
ABATACEPT (6,251)
Which RAVULIZUMAB-CWVZ Alternatives Have Lower Malaise Risk?
RAVULIZUMAB-CWVZ vs REBAMIPIDE
RAVULIZUMAB-CWVZ vs REBETOL
RAVULIZUMAB-CWVZ vs REBIF
RAVULIZUMAB-CWVZ vs REBOXETINE
RAVULIZUMAB-CWVZ vs RECLAST